Denali Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,900
Closed -$111K 469
2023
Q3
$111K Hold
13,900
0.04% 265
2023
Q2
$121K Buy
+13,900
New +$121K 0.04% 254